Summary
Cardinal Health, Inc. (CAH) filed its 2008 10-K report, reflecting a significant period of strategic re-evaluation and operational adjustments. A key development is the active exploration of separating its Healthcare Supply Chain Services and Clinical and Medical Products segments, potentially through a tax-free spin-off of the latter. This move signals a desire to streamline operations and potentially unlock value by creating more focused entities. The company's business is broadly categorized into pharmaceutical and medical supply chain services, clinical technologies, and medical products, each facing distinct competitive landscapes and regulatory environments. Investors should note the company's substantial revenue concentration with its top customers, particularly CVS Caremark and Walgreen Co., which collectively represented a significant portion of fiscal 2008 revenue, highlighting potential risks associated with customer retention. The report also details extensive regulatory oversight across its various segments, including FDA, DEA, and other health agencies, alongside ongoing efforts to ensure compliance and manage associated risks. The company's acquisition and divestiture activities demonstrate a dynamic approach to portfolio management, aiming to align with strategic objectives.
Financial Highlights
31 data points| Revenue | $87.41B |
| Cost of Revenue | $83.63B |
| Gross Profit | $3.78B |
| SG&A Expenses | $2.34B |
| Operating Income | $1.39B |
| Interest Expense | $136.10M |
| Net Income | $1.30B |
| Shares Outstanding (Basic) | 358.20M |
| Shares Outstanding (Diluted) | 364.00M |
Key Highlights
- 1Cardinal Health is actively exploring a separation of its Healthcare Supply Chain Services and Clinical and Medical Products segments, possibly via a spin-off of the Clinical and Medical Products business.
- 2The company's largest customers, CVS Caremark and Walgreen Co., accounted for 22% and 19% of revenue respectively in fiscal 2008, with the top five customers representing 52% of total revenue.
- 3The company operates across four main segments (as of FY2008): Pharmaceutical Supply Chain Services, Medical Supply Chain Services, Clinical Technologies and Services, and Medical Products and Technologies.
- 4Significant acquisitions in recent years include ALARIS Medical Systems, VIASYS Healthcare, and Enturia Inc., indicating strategic growth through acquisition.
- 5The company faces extensive regulatory scrutiny across its operations, including FDA, DEA, and state-level regulations, with potential for civil and criminal penalties for non-compliance.
- 6Cardinal Health has undergone significant divestitures, including parts of its specialty distribution business and its Pharmaceutical Technologies and Services segment.
- 7The company's pharmaceutical supply chain business relies heavily on manufacturer relationships, distribution service agreements, and managing price appreciation and rebates.